ClinicalTrials.Veeva

Menu

Healing of Punch Graft Wounds. Comparative Study Between MariGen and Oasis: a Non-inferiority Study

K

Kerecis

Status

Completed

Conditions

Punch Biopsy Wounds
Healing Times

Treatments

Device: Punch biopsies treated with MariGen Wound ECM dressing
Device: Punch biopsies treated with Oasis ECM dressing

Study type

Interventional

Funder types

Industry

Identifiers

NCT01917591
KS-0070

Details and patient eligibility

About

The objective is to determine, if healing of punch biopsy wounds treated with the fish skin derived MariGen Wound dressing is non-inferior to healing with wounds treated with pig intestines derived Oasis Sheet wound dressing. Secondary endpoints are: Incidence of erythema, Pain, Infection, Quantitative measurements of autoantibodies at baseline and 4 weeks after start of treatment

Enrollment

81 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • >18 yrs
  • Healthy individual
  • Signature of informed consent

Exclusion criteria

  • Autoimmune disease
  • Immunosuppressive treatment
  • Use of addictive drugs
  • Excessive use of alcohol
  • Known fish allergy
  • Known allergy to proteins with porcine origin
  • Peripheral vascular disease
  • Pregnant women
  • Persons receiving anticoagulation therapy or systemic corticosteroids will be excluded.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

81 participants in 2 patient groups

MariGen Wound
Active Comparator group
Description:
Fish derived extra cellular matrix
Treatment:
Device: Punch biopsies treated with MariGen Wound ECM dressing
Oasis Sheet
Active Comparator group
Description:
Pig intestine derived extra cellular matrix
Treatment:
Device: Punch biopsies treated with Oasis ECM dressing

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems